Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

Andres M. Poveda; Frederic Selle; Felix Hilpert; Alexander Reuss; Antonella Savarese; Ignace Vergote; Petronella Witteveen; Aristotelis Bamias; Nana Scotto; Lada Mitchell; Eric Pujade-Lauraine

doi:10.1200/JCO.2015.63.1408

Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

Andres M. Poveda, Frederic Selle, Felix Hilpert, Alexander Reuss, Antonella Savarese, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias, Nana Scotto, Lada Mitchell, Eric Pujade-Lauraine

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

110 Downloads (Pure)

Original language	English
Pages (from-to)	3836-3838
Journal	Journal of Clinical Oncology
Volume	33
Issue number	32
DOIs	https://doi.org/10.1200/JCO.2015.63.1408
Publication status	Published - 10 Nov 2015

Access to Document

10.1200/JCO.2015.63.1408

1408Final published version, 84.8 KB

Cite this

Poveda, A. M., Selle, F., Hilpert, F., Reuss, A., Savarese, A., Vergote, I., Witteveen, P., Bamias, A., Scotto, N., Mitchell, L., & Pujade-Lauraine, E. (2015). Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial. Journal of Clinical Oncology, 33(32), 3836-3838. https://doi.org/10.1200/JCO.2015.63.1408

@article{7b93ea5edfb349ddb2492bc44a18139e,

title = "Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial",

author = "Poveda, {Andres M.} and Frederic Selle and Felix Hilpert and Alexander Reuss and Antonella Savarese and Ignace Vergote and Petronella Witteveen and Aristotelis Bamias and Nana Scotto and Lada Mitchell and Eric Pujade-Lauraine",

year = "2015",

month = nov,

day = "10",

doi = "10.1200/JCO.2015.63.1408",

language = "English",

volume = "33",

pages = "3836--3838",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "32",

}

Poveda, AM, Selle, F, Hilpert, F, Reuss, A, Savarese, A, Vergote, I, Witteveen, P, Bamias, A, Scotto, N, Mitchell, L & Pujade-Lauraine, E 2015, 'Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial', Journal of Clinical Oncology, vol. 33, no. 32, pp. 3836-3838. https://doi.org/10.1200/JCO.2015.63.1408

Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial. / Poveda, Andres M.; Selle, Frederic; Hilpert, Felix et al.
In: Journal of Clinical Oncology, Vol. 33, No. 32, 10.11.2015, p. 3836-3838.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

AU - Poveda, Andres M.

AU - Selle, Frederic

AU - Hilpert, Felix

AU - Reuss, Alexander

AU - Savarese, Antonella

AU - Vergote, Ignace

AU - Witteveen, Petronella

AU - Bamias, Aristotelis

AU - Scotto, Nana

AU - Mitchell, Lada

AU - Pujade-Lauraine, Eric

PY - 2015/11/10

Y1 - 2015/11/10

U2 - 10.1200/JCO.2015.63.1408

DO - 10.1200/JCO.2015.63.1408

M3 - Comment/Letter to the editor

C2 - 26282651

SN - 0732-183X

VL - 33

SP - 3836

EP - 3838

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 32

ER -

Poveda AM, Selle F, Hilpert F, Reuss A, Savarese A, Vergote I et al. Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial. Journal of Clinical Oncology. 2015 Nov 10;33(32):3836-3838. doi: 10.1200/JCO.2015.63.1408